nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—lung cancer	0.316	1	CbGaD
Ceftriaxone—ALB—Gefitinib—lung cancer	0.0836	0.248	CbGbCtD
Ceftriaxone—SLC22A11—Methotrexate—lung cancer	0.0684	0.203	CbGbCtD
Ceftriaxone—ALB—Erlotinib—lung cancer	0.0494	0.147	CbGbCtD
Ceftriaxone—ALB—Irinotecan—lung cancer	0.0446	0.132	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—lung cancer	0.0398	0.118	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—lung cancer	0.0277	0.0822	CbGbCtD
Ceftriaxone—ALB—Methotrexate—lung cancer	0.0236	0.07	CbGbCtD
Ceftriaxone—GLUL—mammary gland—lung cancer	0.0028	0.139	CbGeAlD
Ceftriaxone—GLUL—respiratory system—lung cancer	0.00186	0.0927	CbGeAlD
Ceftriaxone—ALB—mammary gland—lung cancer	0.00173	0.0862	CbGeAlD
Ceftriaxone—GLUL—epithelium—lung cancer	0.00156	0.0775	CbGeAlD
Ceftriaxone—GLUL—bronchus—lung cancer	0.00153	0.0763	CbGeAlD
Ceftriaxone—SLC15A2—mammary gland—lung cancer	0.00145	0.0719	CbGeAlD
Ceftriaxone—GLUL—trachea—lung cancer	0.00138	0.0685	CbGeAlD
Ceftriaxone—SLC15A1—epithelium—lung cancer	0.00129	0.0641	CbGeAlD
Ceftriaxone—GLUL—bone marrow—lung cancer	0.00109	0.0544	CbGeAlD
Ceftriaxone—GLUL—lung—lung cancer	0.000989	0.0492	CbGeAlD
Ceftriaxone—SLC15A2—respiratory system—lung cancer	0.000963	0.0479	CbGeAlD
Ceftriaxone—SLC15A2—bronchus—lung cancer	0.000793	0.0394	CbGeAlD
Ceftriaxone—SLC15A2—trachea—lung cancer	0.000712	0.0354	CbGeAlD
Ceftriaxone—GLUL—lymph node—lung cancer	0.000677	0.0337	CbGeAlD
Ceftriaxone—SLC15A2—lung—lung cancer	0.000511	0.0254	CbGeAlD
Ceftriaxone—Cefotetan—ALB—lung cancer	0.000441	0.267	CrCbGaD
Ceftriaxone—ALB—lymph node—lung cancer	0.000419	0.0209	CbGeAlD
Ceftriaxone—Cefpiramide—ALB—lung cancer	0.000383	0.232	CrCbGaD
Ceftriaxone—SLC15A2—lymph node—lung cancer	0.00035	0.0174	CbGeAlD
Ceftriaxone—Cefonicid—ALB—lung cancer	0.000334	0.202	CrCbGaD
Ceftriaxone—Thrombocytopenia—Gemcitabine—lung cancer	0.000231	0.000882	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—lung cancer	0.000231	0.000881	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Etoposide—lung cancer	0.000229	0.000874	CcSEcCtD
Ceftriaxone—Anaemia—Etoposide—lung cancer	0.000228	0.000871	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Gemcitabine—lung cancer	0.000228	0.000871	CcSEcCtD
Ceftriaxone—Dizziness—Topotecan—lung cancer	0.000227	0.000867	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—lung cancer	0.000227	0.000865	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000226	0.00086	CcSEcCtD
Ceftriaxone—Vomiting—Vinblastine—lung cancer	0.000225	0.000858	CcSEcCtD
Ceftriaxone—Dizziness—Erlotinib—lung cancer	0.000225	0.000858	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Paclitaxel—lung cancer	0.000225	0.000857	CcSEcCtD
Ceftriaxone—Anaemia—Paclitaxel—lung cancer	0.000224	0.000854	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—lung cancer	0.000224	0.000853	CcSEcCtD
Ceftriaxone—Erythema multiforme—Docetaxel—lung cancer	0.000223	0.000851	CcSEcCtD
Ceftriaxone—Malaise—Etoposide—lung cancer	0.000223	0.00085	CcSEcCtD
Ceftriaxone—Agitation—Paclitaxel—lung cancer	0.000223	0.000849	CcSEcCtD
Ceftriaxone—Headache—Vinblastine—lung cancer	0.000222	0.000845	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000221	0.000844	CcSEcCtD
Ceftriaxone—Leukopenia—Etoposide—lung cancer	0.000221	0.000844	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—lung cancer	0.00022	0.00084	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—lung cancer	0.00022	0.00084	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00022	0.000839	CcSEcCtD
Ceftriaxone—Flushing—Docetaxel—lung cancer	0.000219	0.000835	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—lung cancer	0.000219	0.000834	CcSEcCtD
Ceftriaxone—Vomiting—Topotecan—lung cancer	0.000218	0.000833	CcSEcCtD
Ceftriaxone—Malaise—Paclitaxel—lung cancer	0.000218	0.000833	CcSEcCtD
Ceftriaxone—Paraesthesia—Irinotecan—lung cancer	0.000218	0.00083	CcSEcCtD
Ceftriaxone—Leukopenia—Paclitaxel—lung cancer	0.000217	0.000827	CcSEcCtD
Ceftriaxone—Rash—Topotecan—lung cancer	0.000217	0.000826	CcSEcCtD
Ceftriaxone—Hypersensitivity—Vinorelbine—lung cancer	0.000217	0.000826	CcSEcCtD
Ceftriaxone—Dermatitis—Topotecan—lung cancer	0.000216	0.000826	CcSEcCtD
Ceftriaxone—Vomiting—Erlotinib—lung cancer	0.000216	0.000825	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—lung cancer	0.000216	0.000822	CcSEcCtD
Ceftriaxone—Headache—Topotecan—lung cancer	0.000215	0.000821	CcSEcCtD
Ceftriaxone—Rash—Erlotinib—lung cancer	0.000214	0.000818	CcSEcCtD
Ceftriaxone—Dermatitis—Erlotinib—lung cancer	0.000214	0.000817	CcSEcCtD
Ceftriaxone—Palpitations—Paclitaxel—lung cancer	0.000214	0.000817	CcSEcCtD
Ceftriaxone—Convulsion—Etoposide—lung cancer	0.000214	0.000817	CcSEcCtD
Ceftriaxone—Dyspepsia—Irinotecan—lung cancer	0.000213	0.000814	CcSEcCtD
Ceftriaxone—Headache—Erlotinib—lung cancer	0.000213	0.000812	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—lung cancer	0.000213	0.000812	CcSEcCtD
Ceftriaxone—Paraesthesia—Gemcitabine—lung cancer	0.000212	0.000809	CcSEcCtD
Ceftriaxone—Chills—Docetaxel—lung cancer	0.000212	0.000807	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—lung cancer	0.00021	0.000802	CcSEcCtD
Ceftriaxone—Nausea—Vinblastine—lung cancer	0.00021	0.000801	CcSEcCtD
Ceftriaxone—Convulsion—Paclitaxel—lung cancer	0.00021	0.000801	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—lung cancer	0.000208	0.000794	CcSEcCtD
Ceftriaxone—Pruritus—Vinorelbine—lung cancer	0.000208	0.000793	CcSEcCtD
Ceftriaxone—Discomfort—Etoposide—lung cancer	0.000208	0.000793	CcSEcCtD
Ceftriaxone—Pain—Irinotecan—lung cancer	0.000207	0.000791	CcSEcCtD
Ceftriaxone—Nausea—Topotecan—lung cancer	0.000204	0.000779	CcSEcCtD
Ceftriaxone—Discomfort—Paclitaxel—lung cancer	0.000204	0.000777	CcSEcCtD
Ceftriaxone—Pain—Gemcitabine—lung cancer	0.000202	0.00077	CcSEcCtD
Ceftriaxone—Nausea—Erlotinib—lung cancer	0.000202	0.00077	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Etoposide—lung cancer	0.000202	0.000769	CcSEcCtD
Ceftriaxone—Diarrhoea—Vinorelbine—lung cancer	0.000201	0.000767	CcSEcCtD
Ceftriaxone—Dysgeusia—Docetaxel—lung cancer	0.000201	0.000767	CcSEcCtD
Ceftriaxone—Infection—Etoposide—lung cancer	0.0002	0.000764	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—lung cancer	0.0002	0.000763	CcSEcCtD
Ceftriaxone—Feeling abnormal—Irinotecan—lung cancer	0.0002	0.000762	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—lung cancer	0.000199	0.00076	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—lung cancer	0.000199	0.000758	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Irinotecan—lung cancer	0.000198	0.000756	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Paclitaxel—lung cancer	0.000198	0.000754	CcSEcCtD
Ceftriaxone—Oedema—Paclitaxel—lung cancer	0.000198	0.000754	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—lung cancer	0.000198	0.000754	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Etoposide—lung cancer	0.000197	0.000753	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—lung cancer	0.000197	0.119	CrCbGaD
Ceftriaxone—Infection—Paclitaxel—lung cancer	0.000196	0.000749	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Etoposide—lung cancer	0.000195	0.000744	CcSEcCtD
Ceftriaxone—Feeling abnormal—Gemcitabine—lung cancer	0.000195	0.000742	CcSEcCtD
Ceftriaxone—Dizziness—Vinorelbine—lung cancer	0.000194	0.000741	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—lung cancer	0.000194	0.000741	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Paclitaxel—lung cancer	0.000194	0.000738	CcSEcCtD
Ceftriaxone—Abdominal pain—Irinotecan—lung cancer	0.000192	0.000731	CcSEcCtD
Ceftriaxone—Body temperature increased—Irinotecan—lung cancer	0.000192	0.000731	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000192	0.000731	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000192	0.000731	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Paclitaxel—lung cancer	0.000191	0.000729	CcSEcCtD
Ceftriaxone—Anaemia—Docetaxel—lung cancer	0.00019	0.000724	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—lung cancer	0.000188	0.000718	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000188	0.000716	CcSEcCtD
Ceftriaxone—Vomiting—Vinorelbine—lung cancer	0.000187	0.000713	CcSEcCtD
Ceftriaxone—Body temperature increased—Gemcitabine—lung cancer	0.000187	0.000712	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—lung cancer	0.000186	0.00071	CcSEcCtD
Ceftriaxone—Rash—Vinorelbine—lung cancer	0.000185	0.000707	CcSEcCtD
Ceftriaxone—Dermatitis—Vinorelbine—lung cancer	0.000185	0.000706	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—lung cancer	0.000185	0.000704	CcSEcCtD
Ceftriaxone—Headache—Vinorelbine—lung cancer	0.000184	0.000702	CcSEcCtD
Ceftriaxone—Leukopenia—Docetaxel—lung cancer	0.000184	0.000701	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—lung cancer	0.000182	0.000695	CcSEcCtD
Ceftriaxone—Palpitations—Docetaxel—lung cancer	0.000181	0.000692	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—lung cancer	0.000181	0.000692	CcSEcCtD
Ceftriaxone—Paraesthesia—Etoposide—lung cancer	0.000181	0.000691	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—lung cancer	0.000181	0.000689	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—lung cancer	0.00018	0.000688	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—lung cancer	0.000179	0.000681	CcSEcCtD
Ceftriaxone—Hypersensitivity—Irinotecan—lung cancer	0.000179	0.000681	CcSEcCtD
Ceftriaxone—Convulsion—Docetaxel—lung cancer	0.000178	0.000679	CcSEcCtD
Ceftriaxone—Paraesthesia—Paclitaxel—lung cancer	0.000178	0.000677	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—lung cancer	0.000177	0.000674	CcSEcCtD
Ceftriaxone—Nausea—Vinorelbine—lung cancer	0.000175	0.000666	CcSEcCtD
Ceftriaxone—Dyspepsia—Paclitaxel—lung cancer	0.000174	0.000664	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—lung cancer	0.000174	0.000664	CcSEcCtD
Ceftriaxone—Pain—Etoposide—lung cancer	0.000172	0.000658	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—lung cancer	0.000172	0.000656	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—lung cancer	0.000171	0.000652	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—lung cancer	0.00017	0.000648	CcSEcCtD
Ceftriaxone—Pain—Paclitaxel—lung cancer	0.000169	0.000645	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Docetaxel—lung cancer	0.000168	0.000639	CcSEcCtD
Ceftriaxone—Oedema—Docetaxel—lung cancer	0.000168	0.000639	CcSEcCtD
Ceftriaxone—Pruritus—Gemcitabine—lung cancer	0.000167	0.000637	CcSEcCtD
Ceftriaxone—Infection—Docetaxel—lung cancer	0.000166	0.000635	CcSEcCtD
Ceftriaxone—Feeling abnormal—Etoposide—lung cancer	0.000166	0.000634	CcSEcCtD
Ceftriaxone—Diarrhoea—Irinotecan—lung cancer	0.000166	0.000633	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Etoposide—lung cancer	0.000165	0.000629	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Docetaxel—lung cancer	0.000164	0.000626	CcSEcCtD
Ceftriaxone—Feeling abnormal—Paclitaxel—lung cancer	0.000163	0.000621	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000163	0.00062	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—lung cancer	0.000162	0.000619	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—lung cancer	0.000162	0.098	CrCbGaD
Ceftriaxone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000162	0.000617	CcSEcCtD
Ceftriaxone—Diarrhoea—Gemcitabine—lung cancer	0.000162	0.000616	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—lung cancer	0.000161	0.000615	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—lung cancer	0.000161	0.000613	CcSEcCtD
Ceftriaxone—Dizziness—Irinotecan—lung cancer	0.00016	0.000612	CcSEcCtD
Ceftriaxone—Urticaria—Etoposide—lung cancer	0.00016	0.000611	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—lung cancer	0.00016	0.00061	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—lung cancer	0.00016	0.00061	CcSEcCtD
Ceftriaxone—Abdominal pain—Etoposide—lung cancer	0.000159	0.000608	CcSEcCtD
Ceftriaxone—Body temperature increased—Etoposide—lung cancer	0.000159	0.000608	CcSEcCtD
Ceftriaxone—Urticaria—Paclitaxel—lung cancer	0.000157	0.000599	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—lung cancer	0.000156	0.000596	CcSEcCtD
Ceftriaxone—Body temperature increased—Paclitaxel—lung cancer	0.000156	0.000596	CcSEcCtD
Ceftriaxone—Abdominal pain—Paclitaxel—lung cancer	0.000156	0.000596	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—lung cancer	0.000155	0.00059	CcSEcCtD
Ceftriaxone—Vomiting—Irinotecan—lung cancer	0.000154	0.000588	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—lung cancer	0.000153	0.000584	CcSEcCtD
Ceftriaxone—Rash—Irinotecan—lung cancer	0.000153	0.000583	CcSEcCtD
Ceftriaxone—Dermatitis—Irinotecan—lung cancer	0.000153	0.000583	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—lung cancer	0.000153	0.000582	CcSEcCtD
Ceftriaxone—Headache—Irinotecan—lung cancer	0.000152	0.000579	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—lung cancer	0.000151	0.000574	CcSEcCtD
Ceftriaxone—Paraesthesia—Docetaxel—lung cancer	0.00015	0.000574	CcSEcCtD
Ceftriaxone—Vomiting—Gemcitabine—lung cancer	0.00015	0.000573	CcSEcCtD
Ceftriaxone—Rash—Gemcitabine—lung cancer	0.000149	0.000568	CcSEcCtD
Ceftriaxone—Dermatitis—Gemcitabine—lung cancer	0.000149	0.000567	CcSEcCtD
Ceftriaxone—Hypersensitivity—Etoposide—lung cancer	0.000149	0.000567	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—lung cancer	0.000148	0.000564	CcSEcCtD
Ceftriaxone—Headache—Gemcitabine—lung cancer	0.000148	0.000564	CcSEcCtD
Ceftriaxone—Dyspepsia—Docetaxel—lung cancer	0.000148	0.000563	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—lung cancer	0.000147	0.000562	CcSEcCtD
Ceftriaxone—Hypersensitivity—Paclitaxel—lung cancer	0.000146	0.000556	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—lung cancer	0.000145	0.000553	CcSEcCtD
Ceftriaxone—Nausea—Irinotecan—lung cancer	0.000144	0.000549	CcSEcCtD
Ceftriaxone—Pain—Docetaxel—lung cancer	0.000143	0.000547	CcSEcCtD
Ceftriaxone—Pruritus—Etoposide—lung cancer	0.000143	0.000544	CcSEcCtD
Ceftriaxone—Nausea—Gemcitabine—lung cancer	0.00014	0.000535	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—lung cancer	0.00014	0.000534	CcSEcCtD
Ceftriaxone—Pruritus—Paclitaxel—lung cancer	0.00014	0.000534	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—lung cancer	0.000139	0.000531	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—lung cancer	0.000139	0.000529	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—lung cancer	0.000139	0.000529	CcSEcCtD
Ceftriaxone—Feeling abnormal—Docetaxel—lung cancer	0.000138	0.000527	CcSEcCtD
Ceftriaxone—Diarrhoea—Etoposide—lung cancer	0.000138	0.000526	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—lung cancer	0.000137	0.000524	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Docetaxel—lung cancer	0.000137	0.000523	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—lung cancer	0.000137	0.000522	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—lung cancer	0.000137	0.000521	CcSEcCtD
Ceftriaxone—Diarrhoea—Paclitaxel—lung cancer	0.000135	0.000516	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—lung cancer	0.000134	0.0814	CrCbGaD
Ceftriaxone—Malaise—Methotrexate—lung cancer	0.000133	0.000509	CcSEcCtD
Ceftriaxone—Dizziness—Etoposide—lung cancer	0.000133	0.000509	CcSEcCtD
Ceftriaxone—Abdominal pain—Docetaxel—lung cancer	0.000132	0.000505	CcSEcCtD
Ceftriaxone—Body temperature increased—Docetaxel—lung cancer	0.000132	0.000505	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—lung cancer	0.000132	0.000505	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—lung cancer	0.000132	0.000504	CcSEcCtD
Ceftriaxone—Dizziness—Paclitaxel—lung cancer	0.000131	0.000499	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—lung cancer	0.000131	0.000499	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—lung cancer	0.000128	0.000489	CcSEcCtD
Ceftriaxone—Vomiting—Etoposide—lung cancer	0.000128	0.000489	CcSEcCtD
Ceftriaxone—Rash—Etoposide—lung cancer	0.000127	0.000485	CcSEcCtD
Ceftriaxone—Dermatitis—Etoposide—lung cancer	0.000127	0.000485	CcSEcCtD
Ceftriaxone—Headache—Etoposide—lung cancer	0.000126	0.000482	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—lung cancer	0.000126	0.000482	CcSEcCtD
Ceftriaxone—Vomiting—Paclitaxel—lung cancer	0.000126	0.00048	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—lung cancer	0.000125	0.000479	CcSEcCtD
Ceftriaxone—Rash—Paclitaxel—lung cancer	0.000125	0.000476	CcSEcCtD
Ceftriaxone—Dermatitis—Paclitaxel—lung cancer	0.000125	0.000475	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—lung cancer	0.000124	0.000475	CcSEcCtD
Ceftriaxone—Headache—Paclitaxel—lung cancer	0.000124	0.000472	CcSEcCtD
Ceftriaxone—Hypersensitivity—Docetaxel—lung cancer	0.000123	0.000471	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—lung cancer	0.000121	0.000461	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—lung cancer	0.00012	0.000458	CcSEcCtD
Ceftriaxone—Nausea—Etoposide—lung cancer	0.00012	0.000457	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—lung cancer	0.000119	0.000454	CcSEcCtD
Ceftriaxone—Pruritus—Docetaxel—lung cancer	0.000119	0.000452	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—lung cancer	0.000118	0.000452	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—lung cancer	0.000118	0.000451	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—lung cancer	0.000118	0.000449	CcSEcCtD
Ceftriaxone—Nausea—Paclitaxel—lung cancer	0.000117	0.000448	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—lung cancer	0.000117	0.000445	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—lung cancer	0.000116	0.000441	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—lung cancer	0.000115	0.000438	CcSEcCtD
Ceftriaxone—Diarrhoea—Docetaxel—lung cancer	0.000115	0.000437	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000114	0.00181	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—UGT1A1—lung cancer	0.000113	0.00181	CbGpPWpGaD
Ceftriaxone—Palpitations—Doxorubicin—lung cancer	0.000113	0.000432	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—lung cancer	0.000111	0.000424	CcSEcCtD
Ceftriaxone—Dizziness—Docetaxel—lung cancer	0.000111	0.000423	CcSEcCtD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00011	0.00175	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GNG11—lung cancer	0.000109	0.00174	CbGpPWpGaD
Ceftriaxone—Paraesthesia—Methotrexate—lung cancer	0.000108	0.000414	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—lung cancer	0.000108	0.000411	CcSEcCtD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000108	0.00171	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000107	0.00171	CbGpPWpGaD
Ceftriaxone—Vomiting—Docetaxel—lung cancer	0.000107	0.000406	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—lung cancer	0.000106	0.000406	CcSEcCtD
Ceftriaxone—Rash—Docetaxel—lung cancer	0.000106	0.000403	CcSEcCtD
Ceftriaxone—Dermatitis—Docetaxel—lung cancer	0.000106	0.000403	CcSEcCtD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD9—lung cancer	0.000105	0.00167	CbGpPWpGaD
Ceftriaxone—Headache—Docetaxel—lung cancer	0.000105	0.0004	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000105	0.00166	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000105	0.00166	CbGpPWpGaD
Ceftriaxone—Anaphylactic shock—Doxorubicin—lung cancer	0.000105	0.000399	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—lung cancer	0.000105	0.000399	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ALDOA—lung cancer	0.000104	0.00166	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CAT—lung cancer	0.000104	0.00165	CbGpPWpGaD
Ceftriaxone—Infection—Doxorubicin—lung cancer	0.000104	0.000396	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—lung cancer	0.000103	0.000394	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—lung cancer	0.000102	0.000391	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000101	0.00161	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NCOA3—lung cancer	0.000101	0.00161	CbGpPWpGaD
Ceftriaxone—Hyperhidrosis—Doxorubicin—lung cancer	0.000101	0.000386	CcSEcCtD
Ceftriaxone—ALB—Folate Metabolism—APOA1—lung cancer	0.000101	0.0016	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	9.98e-05	0.00159	CbGpPWpGaD
Ceftriaxone—Nausea—Docetaxel—lung cancer	9.95e-05	0.00038	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—lung cancer	9.95e-05	0.00038	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—HRAS—lung cancer	9.91e-05	0.00158	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Methotrexate—lung cancer	9.88e-05	0.000377	CcSEcCtD
Ceftriaxone—ALB—Selenium Micronutrient Network—SOD2—lung cancer	9.85e-05	0.00157	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ADCY1—lung cancer	9.84e-05	0.00157	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ABCG2—lung cancer	9.84e-05	0.00157	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	9.79e-05	0.00156	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—TF—lung cancer	9.73e-05	0.00155	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	9.67e-05	0.00154	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	9.67e-05	0.00154	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HPGDS—lung cancer	9.65e-05	0.00153	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ENO2—lung cancer	9.65e-05	0.00153	CbGpPWpGaD
Ceftriaxone—Urticaria—Methotrexate—lung cancer	9.6e-05	0.000366	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—PPP2R1B—lung cancer	9.59e-05	0.00153	CbGpPWpGaD
Ceftriaxone—Body temperature increased—Methotrexate—lung cancer	9.55e-05	0.000364	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—lung cancer	9.55e-05	0.000364	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—lung cancer	9.39e-05	0.000358	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—GSTT1—lung cancer	9.36e-05	0.00149	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC34A2—lung cancer	9.35e-05	0.00149	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GCLC—lung cancer	9.25e-05	0.00147	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2A6—lung cancer	9.25e-05	0.00147	CbGpPWpGaD
Ceftriaxone—Dyspepsia—Doxorubicin—lung cancer	9.21e-05	0.000351	CcSEcCtD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	8.99e-05	0.00143	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	8.97e-05	0.00143	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	8.97e-05	0.00143	CbGpPWpGaD
Ceftriaxone—Pain—Doxorubicin—lung cancer	8.94e-05	0.000341	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—lung cancer	8.9e-05	0.000339	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	8.87e-05	0.00141	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ENO1—lung cancer	8.77e-05	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—GNG11—lung cancer	8.63e-05	0.00137	CbGpPWpGaD
Ceftriaxone—Feeling abnormal—Doxorubicin—lung cancer	8.62e-05	0.000329	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—APOA1—lung cancer	8.62e-05	0.00137	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—lung cancer	8.55e-05	0.000326	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—lung cancer	8.55e-05	0.000326	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	8.44e-05	0.00134	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	8.34e-05	0.00133	CbGpPWpGaD
Ceftriaxone—Urticaria—Doxorubicin—lung cancer	8.31e-05	0.000317	CcSEcCtD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PPIA—lung cancer	8.28e-05	0.00132	CbGpPWpGaD
Ceftriaxone—Abdominal pain—Doxorubicin—lung cancer	8.27e-05	0.000315	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—lung cancer	8.27e-05	0.000315	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—lung cancer	8.26e-05	0.000315	CcSEcCtD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—ALDOA—lung cancer	8.21e-05	0.00131	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFC—lung cancer	8.21e-05	0.00131	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—lung cancer	8.21e-05	0.00131	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	8.17e-05	0.0013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	8.15e-05	0.0013	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—lung cancer	8.04e-05	0.00128	CbGpPWpGaD
Ceftriaxone—Dizziness—Methotrexate—lung cancer	7.99e-05	0.000305	CcSEcCtD
Ceftriaxone—ALB—Selenium Micronutrient Network—APOA1—lung cancer	7.98e-05	0.00127	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	7.98e-05	0.00127	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	7.98e-05	0.00127	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KIF5B—lung cancer	7.88e-05	0.00125	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2E1—lung cancer	7.87e-05	0.00125	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NQO1—lung cancer	7.78e-05	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—EGF—lung cancer	7.78e-05	0.00124	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Doxorubicin—lung cancer	7.71e-05	0.000294	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—lung cancer	7.68e-05	0.000293	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—lung cancer	7.62e-05	0.00029	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—lung cancer	7.61e-05	0.00029	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—HRAS—lung cancer	7.6e-05	0.00121	CbGpPWpGaD
Ceftriaxone—Headache—Methotrexate—lung cancer	7.57e-05	0.000289	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	7.43e-05	0.00118	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	7.42e-05	0.00118	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—EGF—lung cancer	7.41e-05	0.00118	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	7.41e-05	0.00118	CbGpPWpGaD
Ceftriaxone—Pruritus—Doxorubicin—lung cancer	7.4e-05	0.000282	CcSEcCtD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TF—lung cancer	7.21e-05	0.00115	CbGpPWpGaD
Ceftriaxone—Nausea—Methotrexate—lung cancer	7.17e-05	0.000274	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—lung cancer	7.16e-05	0.000273	CcSEcCtD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A18—lung cancer	7.09e-05	0.00113	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—STK11—lung cancer	7.01e-05	0.00112	CbGpPWpGaD
Ceftriaxone—Dizziness—Doxorubicin—lung cancer	6.92e-05	0.000264	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	6.89e-05	0.0011	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AVP—lung cancer	6.74e-05	0.00107	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	6.66e-05	0.00106	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	6.66e-05	0.00106	CbGpPWpGaD
Ceftriaxone—Vomiting—Doxorubicin—lung cancer	6.65e-05	0.000254	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—lung cancer	6.59e-05	0.000252	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—lung cancer	6.59e-05	0.000251	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—lung cancer	6.55e-05	0.00025	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCB1—lung cancer	6.53e-05	0.00104	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTP1—lung cancer	6.49e-05	0.00103	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KDM1A—lung cancer	6.47e-05	0.00103	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL2—lung cancer	6.46e-05	0.00103	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APP—lung cancer	6.43e-05	0.00102	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.34e-05	0.00101	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CAT—lung cancer	6.31e-05	0.001	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	6.23e-05	0.000991	CbGpPWpGaD
Ceftriaxone—Nausea—Doxorubicin—lung cancer	6.21e-05	0.000237	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	6.19e-05	0.000985	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ABCB1—lung cancer	6.14e-05	0.000977	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	6.13e-05	0.000975	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	6.03e-05	0.00096	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TYMS—lung cancer	6.03e-05	0.000959	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTM1—lung cancer	5.96e-05	0.000948	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	5.78e-05	0.000919	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP1A1—lung cancer	5.65e-05	0.000899	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ERCC2—lung cancer	5.6e-05	0.000892	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	5.6e-05	0.000891	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—lung cancer	5.53e-05	0.00088	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD9—lung cancer	5.42e-05	0.000863	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—APOA1—lung cancer	5.15e-05	0.00082	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	5.14e-05	0.000818	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	5.12e-05	0.000814	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	4.98e-05	0.000792	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOA1—lung cancer	4.85e-05	0.000771	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	4.84e-05	0.00077	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AZIN2—lung cancer	4.79e-05	0.000762	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COL4A3BP—lung cancer	4.79e-05	0.000762	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	4.76e-05	0.000758	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—lung cancer	4.7e-05	0.000748	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FGR—lung cancer	4.7e-05	0.000748	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—lung cancer	4.66e-05	0.000742	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—lung cancer	4.48e-05	0.000713	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.47e-05	0.00071	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNG11—lung cancer	4.45e-05	0.000707	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CG—lung cancer	4.43e-05	0.000704	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	4.42e-05	0.000703	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—AVP—lung cancer	4.39e-05	0.000698	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—CREBBP—lung cancer	4.36e-05	0.000694	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.32e-05	0.000688	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	4.29e-05	0.000683	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPIA—lung cancer	4.27e-05	0.000679	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC3—lung cancer	4.25e-05	0.000675	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFC—lung cancer	4.23e-05	0.000674	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ALDOA—lung cancer	4.23e-05	0.000674	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—POMC—lung cancer	4.21e-05	0.00067	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	4.16e-05	0.000661	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—lung cancer	4.15e-05	0.00066	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CREBBP—lung cancer	4.1e-05	0.000653	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—lung cancer	4.08e-05	0.00065	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ATP5H—lung cancer	4.07e-05	0.000648	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.03e-05	0.000641	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	3.93e-05	0.000625	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPP2R1B—lung cancer	3.9e-05	0.00062	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CD—lung cancer	3.89e-05	0.000619	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GNG11—lung cancer	3.85e-05	0.000612	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—lung cancer	3.84e-05	0.000611	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—lung cancer	3.82e-05	0.000608	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—lung cancer	3.8e-05	0.000604	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	3.77e-05	0.0006	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.74e-05	0.000595	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.74e-05	0.000595	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TF—lung cancer	3.72e-05	0.000591	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—RAF1—lung cancer	3.69e-05	0.000588	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IRF1—lung cancer	3.64e-05	0.000579	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLBD1—lung cancer	3.63e-05	0.000577	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.57e-05	0.000568	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	3.5e-05	0.000557	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	3.49e-05	0.000555	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	3.46e-05	0.000551	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	3.46e-05	0.000551	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	3.45e-05	0.000549	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	3.41e-05	0.000543	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CB—lung cancer	3.39e-05	0.00054	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—lung cancer	3.36e-05	0.000535	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	3.33e-05	0.000529	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD17B10—lung cancer	3.32e-05	0.000528	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APP—lung cancer	3.31e-05	0.000527	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	3.28e-05	0.000522	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TF—lung cancer	3.22e-05	0.000512	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	3.17e-05	0.000504	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	3.11e-05	0.000495	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CKB—lung cancer	3.09e-05	0.000491	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	3.07e-05	0.000488	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—lung cancer	3.02e-05	0.00048	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTEN—lung cancer	2.93e-05	0.000466	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CNDP2—lung cancer	2.9e-05	0.000462	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM2—lung cancer	2.9e-05	0.000462	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTMR3—lung cancer	2.82e-05	0.000449	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	2.82e-05	0.000448	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—EP300—lung cancer	2.79e-05	0.000445	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.78e-05	0.000442	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PGAM1—lung cancer	2.75e-05	0.000438	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	2.74e-05	0.000436	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	2.67e-05	0.000425	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGB1—lung cancer	2.65e-05	0.000421	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2A7—lung cancer	2.62e-05	0.000417	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	2.6e-05	0.000414	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SDC4—lung cancer	2.57e-05	0.000408	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	2.46e-05	0.000391	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	2.35e-05	0.000374	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—RRM1—lung cancer	2.34e-05	0.000372	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA3—lung cancer	2.34e-05	0.000372	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AVP—lung cancer	2.23e-05	0.000355	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—B4GALT5—lung cancer	2.2e-05	0.00035	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	2.16e-05	0.000344	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	2.14e-05	0.000341	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA4—lung cancer	2.14e-05	0.00034	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.09e-05	0.000333	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	2.09e-05	0.000332	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA2—lung cancer	2.08e-05	0.000332	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—lung cancer	2.07e-05	0.000329	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MMP1—lung cancer	2.06e-05	0.000328	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA1—lung cancer	2.01e-05	0.00032	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCC3—lung cancer	1.99e-05	0.000316	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.97e-05	0.000314	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—lung cancer	1.97e-05	0.000313	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKR1C1—lung cancer	1.93e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UGT1A1—lung cancer	1.87e-05	0.000297	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GNG11—lung cancer	1.8e-05	0.000287	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CG—lung cancer	1.8e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.79e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—EGF—lung cancer	1.78e-05	0.000283	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOA—lung cancer	1.72e-05	0.000273	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.71e-05	0.000271	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—lung cancer	1.69e-05	0.000269	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CREBBP—lung cancer	1.67e-05	0.000265	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA3—lung cancer	1.67e-05	0.000265	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.64e-05	0.00026	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.63e-05	0.000259	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADCY1—lung cancer	1.62e-05	0.000258	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG2—lung cancer	1.62e-05	0.000258	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HPGDS—lung cancer	1.59e-05	0.000253	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENO2—lung cancer	1.59e-05	0.000253	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CD—lung cancer	1.58e-05	0.000252	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP2R1B—lung cancer	1.58e-05	0.000251	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.56e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTT1—lung cancer	1.54e-05	0.000245	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2A6—lung cancer	1.52e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCLC—lung cancer	1.52e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.52e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENO1—lung cancer	1.44e-05	0.00023	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.44e-05	0.00023	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.44e-05	0.000229	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RAF1—lung cancer	1.41e-05	0.000225	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CB—lung cancer	1.38e-05	0.000219	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.33e-05	0.000212	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2E1—lung cancer	1.3e-05	0.000206	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NQO1—lung cancer	1.28e-05	0.000204	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL2—lung cancer	1.27e-05	0.000201	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.25e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.24e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.22e-05	0.000194	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STK11—lung cancer	1.16e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—EP300—lung cancer	1.14e-05	0.000181	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SRC—lung cancer	1.1e-05	0.000176	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.08e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—lung cancer	1.08e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTP1—lung cancer	1.07e-05	0.00017	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NRAS—lung cancer	1.06e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAT—lung cancer	1.04e-05	0.000165	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.03e-05	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK3—lung cancer	1.02e-05	0.000162	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCB1—lung cancer	1.01e-05	0.000161	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TYMS—lung cancer	9.94e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—lung cancer	9.82e-06	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP1A1—lung cancer	9.31e-06	0.000148	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ERCC2—lung cancer	9.23e-06	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KRAS—lung cancer	9.15e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—lung cancer	8.4e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—lung cancer	8.13e-06	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—lung cancer	7.99e-06	0.000127	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HRAS—lung cancer	7.77e-06	0.000124	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.65e-06	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CG—lung cancer	7.29e-06	0.000116	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—POMC—lung cancer	6.94e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—lung cancer	6.86e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CREBBP—lung cancer	6.76e-06	0.000108	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CD—lung cancer	6.41e-06	0.000102	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CB—lung cancer	5.59e-06	8.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—lung cancer	5.54e-06	8.81e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTEN—lung cancer	4.83e-06	7.68e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—EP300—lung cancer	4.61e-06	7.33e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—lung cancer	3.41e-06	5.42e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—lung cancer	2.78e-06	4.43e-05	CbGpPWpGaD
